Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 9Withdrawn 6Active not recruiting 5Terminated 2Recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 49INDUSTRY 13NETWORK 5NIH 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 2Breast 2Gynecologic 1Gastrointestinal 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Ovarian Neoplasms 1Gastric and Esophagogastric Junction Adenocarcinoma 1Breast Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Specimen Handling 19Cyclophosphamide 18Magnetic Resonance Spectroscopy 17Vincristine 16Dexamethasone 15Radiotherapy 14Cisplatin 14Radiation 12Etoposide 11Doxorubicin 11Radiotherapy, Intensity-Modulated 10Carboplatin 10durvalumab 9Paclitaxel 9Cytarabine 8Temozolomide 7Rituximab 7Radiotherapy, Conformal 7Prednisone 7Lenalidomide 7Irinotecan 7Gemcitabine 7Fluorouracil 7Docetaxel 7Bortezomib 7Biopsy 7daratumumab 6Platinum 6Leucovorin 6Capecitabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × Drug Therapy × Clear all
NCT05710328 2026-05-05

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
235 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

NCT05633602 2026-04-17

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

SWOG Cancer Research Network

Phase 3 Active not recruiting
838 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03939481 2026-04-13

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

SWOG Cancer Research Network

Active not recruiting
1,336 enrolled
GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms

NCT03283384 2025-09-19

NEOLBC

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
100 enrolled
Breast

Breast Neoplasms

NCT03443856 2024-01-05

VESTIGE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
197 enrolled
Gastrointestinal

Gastric and Esophagogastric Junction Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡